Treatment of Aspergillosis

by Jeffrey D. Jenks, Martin Hoenigl
Published 2018-08-01

Latent Tuberculosis Screening Using Electronic Health Record Data

by Jeffrey D. Jenks, Richard S. Garfein, Wenhong Zhu, Michael Hogarth
Published 2020-09-01

Blood Aspergillus PCR: The Good, the Bad, and the Ugly

by Matthias Egger, Jeffrey D. Jenks, Martin Hoenigl, Juergen Prattes
Published 2020-01-01

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

by Amir Arastehfar, Toni Gabaldón, Rocio Garcia-Rubio, Jeffrey D. Jenks, Martin Hoenigl, Helmut J. F. Salzer, Macit Ilkit, Cornelia Lass-Flörl, David S. Perlin
Published 2020-12-01

COVID-19 Associated Pulmonary Aspergillosis (CAPA)—From Immunology to Treatment

by Amir Arastehfar, Agostinho Carvalho, Frank L. van de Veerdonk, Jeffrey D. Jenks, Philipp Koehler, Robert Krause, Oliver A. Cornely, David S. Perlin, Cornelia Lass-Flörl, Martin Hoenigl
Published 2020-06-01

Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

by Jeffrey D. Jenks, Jean-Pierre Gangneux, Ilan S. Schwartz, Ana Alastruey-Izquierdo, Katrien Lagrou, George R. Thompson III, Cornelia Lass-Flörl, Martin Hoenigl, European Confederation of Medical Mycology (ECMM) Council Investigators
Published 2020-10-01

Using Interleukin 6 and 8 in Blood and Bronchoalveolar Lavage Fluid to Predict Survival in Hematological Malignancy Patients With Suspected Pulmonary Mold Infection

by Stephen A. Rawlings, Sven Heldt, Sven Heldt, Juergen Prattes, Susanne Eigl, Jeffrey D. Jenks, Holger Flick, Jasmin Rabensteiner, Florian Prüller, Albert Wölfler, Peter Neumeister, Heimo Strohmaier, Robert Krause, Robert Krause, Martin Hoenigl, Martin Hoenigl, Martin Hoenigl
Published 2019-08-01